These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 32647807)
21. Factors Associated with Good Patient Outcomes Following Convalescent Plasma in COVID-19: A Prospective Phase II Clinical Trial. Ibrahim D; Dulipsingh L; Zapatka L; Eadie R; Crowell R; Williams K; Wakefield DB; Cook L; Puff J; Hussain SA Infect Dis Ther; 2020 Dec; 9(4):913-926. PubMed ID: 32951151 [TBL] [Abstract][Full Text] [Related]
22. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial. Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924 [TBL] [Abstract][Full Text] [Related]
23. Current views on the potentials of convalescent plasma therapy (CPT) as Coronavirus disease 2019 (COVID-19) treatment: A systematic review and meta-analysis based on recent studies and previous respiratory pandemics. Aviani JK; Halim D; Soeroto AY; Achmad TH; Djuwantono T Rev Med Virol; 2021 Nov; 31(6):e2225. PubMed ID: 33621405 [TBL] [Abstract][Full Text] [Related]
24. Regulatory consideration on preparation and clinical use of COVID-19 convalescent plasma. Yılmaz S; Ertuğrul Örüç N; Özcebe Oİ; Azap A; Çetin AT; Yenicesu İ; Öztürk A; Gündüz M; Tekin A Transfus Apher Sci; 2020 Oct; 59(5):102846. PubMed ID: 32593519 [TBL] [Abstract][Full Text] [Related]
25. Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial. Li L; Zhang W; Hu Y; Tong X; Zheng S; Yang J; Kong Y; Ren L; Wei Q; Mei H; Hu C; Tao C; Yang R; Wang J; Yu Y; Guo Y; Wu X; Xu Z; Zeng L; Xiong N; Chen L; Wang J; Man N; Liu Y; Xu H; Deng E; Zhang X; Li C; Wang C; Su S; Zhang L; Wang J; Wu Y; Liu Z JAMA; 2020 Aug; 324(5):460-470. PubMed ID: 32492084 [TBL] [Abstract][Full Text] [Related]
26. Early safety indicators of COVID-19 convalescent plasma in 5000 patients. Joyner MJ; Wright RS; Fairweather D; Senefeld JW; Bruno KA; Klassen SA; Carter RE; Klompas AM; Wiggins CC; Shepherd JR; Rea RF; Whelan ER; Clayburn AJ; Spiegel MR; Johnson PW; Lesser ER; Baker SE; Larson KF; Ripoll JG; Andersen KJ; Hodge DO; Kunze KL; Buras MR; Vogt MN; Herasevich V; Dennis JJ; Regimbal RJ; Bauer PR; Blair JE; Van Buskirk CM; Winters JL; Stubbs JR; Paneth NS; Verdun NC; Marks P; Casadevall A J Clin Invest; 2020 Sep; 130(9):4791-4797. PubMed ID: 32525844 [TBL] [Abstract][Full Text] [Related]